1,481 Shares in Bath & Body Works, Inc. (NYSE:BBWI) Purchased by Friedenthal Financial

Friedenthal Financial bought a new stake in Bath & Body Works, Inc. (NYSE:BBWI) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,481 shares of the company’s stock, valued at approximately $57,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in BBWI. Anomaly Capital Management LP acquired a new position in shares of Bath & Body Works in the second quarter valued at approximately $113,995,000. FMR LLC raised its holdings in Bath & Body Works by 17,496.5% in the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after acquiring an additional 2,501,828 shares during the last quarter. KBC Group NV lifted its stake in shares of Bath & Body Works by 9,023.5% during the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after purchasing an additional 1,683,160 shares during the period. Erste Asset Management GmbH acquired a new stake in shares of Bath & Body Works during the third quarter worth $50,483,000. Finally, Lone Pine Capital LLC grew its position in shares of Bath & Body Works by 15.8% in the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after purchasing an additional 1,547,399 shares during the period. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Trading Up 0.9 %

NYSE:BBWI traded up $0.34 on Monday, reaching $36.75. The stock had a trading volume of 3,482,889 shares, compared to its average volume of 3,142,947. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99. The stock has a market cap of $7.96 billion, a P/E ratio of 8.96, a price-to-earnings-growth ratio of 1.43 and a beta of 1.82. The company has a 50-day moving average of $35.75 and a 200 day moving average of $33.68.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Bath & Body Works’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.48 earnings per share. On average, equities analysts predict that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.18%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works’s payout ratio is currently 19.51%.

Wall Street Analysts Forecast Growth

BBWI has been the topic of several recent analyst reports. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $42.00 to $48.00 in a research report on Friday. Argus restated a “hold” rating on shares of Bath & Body Works in a report on Friday. TD Cowen lifted their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. JPMorgan Chase & Co. increased their target price on Bath & Body Works from $35.00 to $39.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 26th. Finally, Piper Sandler lifted their price objective on Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $43.06.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.